Chicago Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Chicago Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$163K	–	32
2025 Q4	$163K	Buy	+10,000	New	+$194K	0.11%	43

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Chicago Capital Management's AVDL Position: Q1 2026 in Review

Chicago Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 10,000 shares — an estimated $163K sold.

Chicago Capital Management first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $163K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Chicago Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Chicago Capital Management sold 10,000 Avadel Pharmaceuticals shares in Q1 2026, an estimated $163K.
Chicago Capital Management first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Chicago Capital Management's Avadel Pharmaceuticals position peaked at $163K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Chicago Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.